Cotec Healthcare Ltd, the pharmaceutical formulations manufacturer headquartered in Uttarakhand, has filed its draft red herring prospectus (DRHP) with the SEBI (Securities and Exchange Board of India) for its initial public offering (IPO).
The company seeks to raise ₹295 crore through a fresh issuance of shares, with an offer-for-sale (OFS) of up to 6,000,000 shares, as per the DRHP.
Harsh Tiwari and Vandana Tiwari are the promoters of the company and will be divesting their stake through the OFS route.
According to the DRHP:
The company proposes to utilise the net proceeds from the IPO for the following purposes:
Cotec Healthcare is headquartered in Uttarakhand and is India’s second-largest contract development and manufacturing organisation (CDMO) in terms of the number of dosage forms.
The company has capabilities across 24 distinct types of formulations and offers products in various dosage forms. These include injectables, tablets, eye drops, capsules, ampoules, vials, ointments, dry and liquid syrups and infusions. The company has a manufacturing facility at Roorkee with an aggregate installed capacity of 4,051.38 million units.
Cotec Healthcare Ltd also earned a net profit of ₹20 crore for FY25, while revenues from operations stood at ₹192.2 crore.